Jingjing Kang

1.9k total citations
60 papers, 1.3k citations indexed

About

Jingjing Kang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jingjing Kang has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Jingjing Kang's work include Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (10 papers) and Extracellular vesicles in disease (9 papers). Jingjing Kang is often cited by papers focused on Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (10 papers) and Extracellular vesicles in disease (9 papers). Jingjing Kang collaborates with scholars based in China, United States and Belarus. Jingjing Kang's co-authors include Fei Mao, Xu Zhang, Wenrong Xu, Hui Qian, Yongmin Yan, Yunbing Wu, Xudong Tang, Bin Zhang, Zhouguang Hui and Xin Sun and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jingjing Kang

56 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingjing Kang China 20 472 285 171 165 164 60 1.3k
Wenting Li China 21 446 0.9× 179 0.6× 102 0.6× 153 0.9× 185 1.1× 89 1.4k
Vasiliki Galani Greece 18 469 1.0× 183 0.6× 130 0.8× 160 1.0× 145 0.9× 49 1.2k
Jianfeng Wang China 21 472 1.0× 179 0.6× 126 0.7× 419 2.5× 308 1.9× 81 1.5k
Shanmin Yang United States 21 790 1.7× 132 0.5× 179 1.0× 168 1.0× 174 1.1× 54 1.6k
Maria João Pires Portugal 16 529 1.1× 137 0.5× 133 0.8× 151 0.9× 125 0.8× 66 1.4k
Shannon D. McClintock United States 18 375 0.8× 152 0.5× 85 0.5× 144 0.9× 315 1.9× 38 1.2k
Onn Haji Hashim Malaysia 26 933 2.0× 156 0.5× 230 1.3× 220 1.3× 254 1.5× 114 2.0k
Rebecca E. Oberley‐Deegan United States 23 619 1.3× 420 1.5× 148 0.9× 173 1.0× 459 2.8× 72 1.8k
Yuan Ruan China 22 798 1.7× 409 1.4× 284 1.7× 146 0.9× 135 0.8× 92 1.6k

Countries citing papers authored by Jingjing Kang

Since Specialization
Citations

This map shows the geographic impact of Jingjing Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjing Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjing Kang more than expected).

Fields of papers citing papers by Jingjing Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingjing Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjing Kang. The network helps show where Jingjing Kang may publish in the future.

Co-authorship network of co-authors of Jingjing Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Jingjing Kang. A scholar is included among the top collaborators of Jingjing Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingjing Kang. Jingjing Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Jiantong, Zhuo Ye, Jingjing Kang, et al.. (2025). Endogenous HClO-Gated Cascade MicroRNA Imaging for Precise Diagnosis of Atherosclerosis In Vivo. Journal of the American Chemical Society. 147(8). 7113–7126. 6 indexed citations
2.
Wang, Xiang, Jiantong Dong, Jingjing Kang, et al.. (2025). Self-Adaptive Release of Stem Cell-Derived Exosomes from a Multifunctional Hydrogel for Accelerating MRSA-Infected Diabetic Wound Repair. Journal of the American Chemical Society. 147(19). 16362–16378. 13 indexed citations
3.
4.
5.
Fu, Jiamei, Qing Shao, Ying Zhang, et al.. (2025). Reducing radiation pneumonitis in lung cancer patients: from Chinese expert consensus to practice. Translational Lung Cancer Research. 14(7). 2747–2759.
6.
7.
Sun, Ning, Xiaoqing Yang, Jingqi Li, et al.. (2024). Unveiling urinary extracellular vesicle mRNA signature for early diagnosis and prognosis of bladder cancer. Theranostics. 15(4). 1272–1284. 4 indexed citations
8.
Yan, Yujie, Jingjing Kang, Qian Cheng, et al.. (2024). Reducing the risk of grade 3 or greater radiation pneumonitis after radical radiotherapy to the lung.. Journal of Clinical Oncology. 42(16_suppl). e20008–e20008. 1 indexed citations
9.
Wu, Leilei, Bo Cheng, Xiaojiang Sun, et al.. (2024). Induction immunochemotherapy followed by definitive chemoradiotherapy for unresectable locally advanced non‐small cell lung cancer: a multi‐institutional retrospective cohort study. SHILAP Revista de lepidopterología. 5(3). e501–e501. 6 indexed citations
10.
Wu, Yuchen, Shuang Guo, Kunli Wang, & Jingjing Kang. (2023). The interaction of peptide inhibitors and Aβ protein: Binding mode analysis, inhibition of the formation of Aβ aggregates, and then exert neuroprotective effects. Frontiers in Aging Neuroscience. 15. 1139418–1139418. 4 indexed citations
11.
12.
Zhang, Ran, Jingjing Kang, Shengxiang Ren, Ligang Xing, & Yaping Xu. (2022). Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis. Annals of Translational Medicine. 10(2). 104–104. 13 indexed citations
13.
Ma, Li, Yu Men, Jingjing Kang, et al.. (2019). A current review of dose-escalated radiotherapy in locally advanced non-small cell lung cancer. Radiology and Oncology. 53(1). 6–14. 32 indexed citations
14.
Kang, Jingjing, et al.. (2019). Tumor Mutation Load: A Novel Independent Prognostic Factor in Stage IIIA-N2 Non-Small-Cell Lung Cancer. Disease Markers. 2019. 1–10. 6 indexed citations
15.
Kang, Jingjing, Matthew S. Ning, Han Feng, et al.. (2019). Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms. International Journal of Radiation Oncology*Biology*Physics. 106(1). 90–99. 28 indexed citations
16.
Mao, Fei, Jingjing Kang, Xiu Jun Cai, et al.. (2017). Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer. Współczesna Onkologia. 2(2). 91–97. 17 indexed citations
17.
Liu, Xiaoning, Jingjing Kang, Hui Wang, & Tao Huang. (2017). Mitochondrial ROS contribute to oridonin-induced HepG2 apoptosis through PARP activation. Oncology Letters. 15(3). 2881–2888. 16 indexed citations
18.
Gao, Wenjuan, Yang Xu, Jingjing Kang, et al.. (2013). Tolerogenic Vaccination Reduced Effector Memory CD4 T Cells and Induced Effector Memory Treg Cells for Type I Diabetes Treatment. PLoS ONE. 8(7). e70056–e70056. 10 indexed citations
19.
Gao, Wenjuan, Shiwen Chen, Jingyao Zhang, et al.. (2013). Mushroom lectin enhanced immunogenicity of HBV DNA vaccine in C57BL/6 and HBsAg-transgenic mice. Vaccine. 31(18). 2273–2280. 35 indexed citations
20.
Kang, Jingjing, Yushun Zhang, Xiang Cao, et al.. (2011). Lycorine inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in RAW264.7 cells through suppressing P38 and STATs activation and increases the survival rate of mice after LPS challenge. International Immunopharmacology. 12(1). 249–256. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenting Li Breakdown of academic impact, for papers by Vasiliki Galani Breakdown of academic impact, for papers by Jianfeng Wang Breakdown of academic impact, for papers by Shanmin Yang Breakdown of academic impact, for papers by Maria João Pires Breakdown of academic impact, for papers by Shannon D. McClintock Breakdown of academic impact, for papers by Onn Haji Hashim Breakdown of academic impact, for papers by Rebecca E. Oberley‐Deegan Breakdown of academic impact, for papers by Yuan Ruan
Rankless by CCL
2026